Cargando…
Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer
BACKGROUND: Breast cancer is the most prevalent cancer among women worldwide. WZ35, an analog of curcumin, has been demonstrated to remarkably improve the pharmacokinetic profiles in vivo compared with curcumin. WZ35 exhibits promising antitumor activity in gastric cancer, HCC, colon cancer. However...
Autores principales: | Wang, Lihua, Wang, Canwei, Tao, Zheying, Zhao, Liqian, Zhu, Zheng, Wu, Wencan, He, Ye, Chen, Hong, Zheng, Bin, Huang, Xiangjie, Yu, Yun, Yang, Linjun, Liang, Guang, Cui, Ri, Chen, Tongke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842168/ https://www.ncbi.nlm.nih.gov/pubmed/31703744 http://dx.doi.org/10.1186/s13046-019-1424-4 |
Ejemplares similares
-
ROS generation mediates the anti-cancer effects of WZ35 via activating JNK and ER stress apoptotic pathways in gastric cancer
por: Zou, Peng, et al.
Publicado: (2015) -
A novel small molecule glycolysis inhibitor WZ35 exerts anti-cancer effect via metabolic reprogramming
por: Wang, Lihua, et al.
Publicado: (2022) -
Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics
por: Wang, Lihua, et al.
Publicado: (2017) -
Curcumin analog WZ26 induces ROS and cell death via inhibition of STAT3 in cholangiocarcinoma
por: Chen, Minxiao, et al.
Publicado: (2023) -
Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells
por: Zhang, Xiuhua, et al.
Publicado: (2015)